AnalystsBill Maughan
Bill Maughan's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 8%
#4781 out of 5184 analysts
Average Return
-14.45%
Win Rate
33%5 out of 15
Risk vs Reward
Poor
Good

Bill Maughan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Merus NvMRUS
+129.26%$21.94$50.30
2023-11-01 -
2024-11-01
Strong Buy
Krystal Biotech IncKRYS
+96.32%$139.01$272.91
2025-06-30 -
2026-01-28
Strong Buy
Wave Life Sciences LtdWVE
+57.35%$8.09$12.73
2025-10-14 -
2026-01-28
Strong Buy
Annexon IncANNX
+54.93%$4.06$6.29
2025-12-01 -
2026-01-28
Strong Buy
Dianthus Therapeutics IncDNTH
+29.89%$38.88$50.50
2025-09-16 -
2026-01-28
Strong Buy

Bill Maughan Analyst Color

Get additional color on Bill Maughan's coverage of popular stocks

Bill Maughan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Cellectis SaCLLS
1Strong Buy$9.00+121.67%Initiates Coverage On
a month ago
Wave Life Sciences LtdWVE
2Strong Buy$47.00+269.21%Maintains
2 months ago
Annexon IncANNX
1Strong Buy$17.00+170.27%Initiates Coverage On
2 months ago
Korro Bio IncKRRO
1Strong Buy$93.00+695.55%Initiates Coverage On
3 months ago
Dianthus Therapeutics IncDNTH
1Strong Buy$100.00+98.02%Initiates Coverage On
4 months ago
Y Mabs Therapeutics IncYMAB
3Hold$8.60-0.12%Downgrades
6 months ago
Krystal Biotech IncKRYS
1Strong Buy$190.00-30.38%Initiates Coverage On
7 months ago
Crispr Therapeutics AgCRSP
1Hold$45.00-16.19%Downgrades
7 months ago
Nkarta IncNKTX
2Strong Buy$15.00N/AMaintains
2 years ago
Fate Therapeutics IncFATE
1Strong Buy$9.00N/AMaintains
2 years ago
Immunocore Holdings PLCIMCR
3Hold$67.00N/AMaintains
2 years ago
Moderna IncMRNA
3Hold$106.00N/AMaintains
2 years ago
Century Therapeutics IncIPSC
1Strong Buy$24.00N/AMaintains
2 years ago
Bicycle Therapeutics PLCBCYC
1Strong Buy$60.00N/AReiterates
2 years ago
Merus NvMRUS
1Strong Buy$45.00N/AInitiates Coverage On
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.